PlainRecalls
FDA Drug Moderate Class II Terminated

Doxycycline Hyclate Tablets USP, 100 mg, packaged in a) 50-count bottle (NDC 0143-2112-50), b) 500-count bottle (NDC 0143-2112-05), Rx only, Mfd. by: West-Ward Pharmaceuticals Corp., Eatontown, NJ 07724.

Reported: June 3, 2020 Initiated: May 13, 2020 #D-1274-2020

Product Description

Doxycycline Hyclate Tablets USP, 100 mg, packaged in a) 50-count bottle (NDC 0143-2112-50), b) 500-count bottle (NDC 0143-2112-05), Rx only, Mfd. by: West-Ward Pharmaceuticals Corp., Eatontown, NJ 07724.

Reason for Recall

Failed dissolution specification: The dissolution test at the 24 month time point (end of shelf life) yielded an out of specification result.

Details

Recalling Firm
West-Ward Columbus Inc
Units Affected
68,376 bottles
Distribution
USA Nationwide
Location
Columbus, OH

Frequently Asked Questions

What product was recalled?
Doxycycline Hyclate Tablets USP, 100 mg, packaged in a) 50-count bottle (NDC 0143-2112-50), b) 500-count bottle (NDC 0143-2112-05), Rx only, Mfd. by: West-Ward Pharmaceuticals Corp., Eatontown, NJ 07724.. Recalled by West-Ward Columbus Inc. Units affected: 68,376 bottles.
Why was this product recalled?
Failed dissolution specification: The dissolution test at the 24 month time point (end of shelf life) yielded an out of specification result.
Which agency issued this recall?
This recall was issued by the FDA Drug on June 3, 2020. Severity: Moderate. Recall number: D-1274-2020.